Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
2.
Nat Biotechnol ; 26(8): 925-32, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18641636

RESUMO

Antibody-drug conjugates enhance the antitumor effects of antibodies and reduce adverse systemic effects of potent cytotoxic drugs. However, conventional drug conjugation strategies yield heterogenous conjugates with relatively narrow therapeutic index (maximum tolerated dose/curative dose). Using leads from our previously described phage display-based method to predict suitable conjugation sites, we engineered cysteine substitutions at positions on light and heavy chains that provide reactive thiol groups and do not perturb immunoglobulin folding and assembly, or alter antigen binding. When conjugated to monomethyl auristatin E, an antibody against the ovarian cancer antigen MUC16 is as efficacious as a conventional conjugate in mouse xenograft models. Moreover, it is tolerated at higher doses in rats and cynomolgus monkeys than the same conjugate prepared by conventional approaches. The favorable in vivo properties of the near-homogenous composition of this conjugate suggest that our strategy offers a general approach to retaining the antitumor efficacy of antibody-drug conjugates, while minimizing their systemic toxicity.


Assuntos
Anticorpos Antineoplásicos/farmacologia , Antineoplásicos/farmacologia , Citotoxinas/farmacologia , Imunotoxinas/farmacocinética , Neoplasias Ovarianas/imunologia , Animais , Anticorpos Monoclonais/genética , Anticorpos Monoclonais/farmacologia , Anticorpos Antineoplásicos/genética , Especificidade de Anticorpos , Sítios de Ligação , Antígeno Ca-125/imunologia , Linhagem Celular Tumoral , Química Farmacêutica/métodos , Cisteína/genética , Feminino , Humanos , Macaca fascicularis , Proteínas de Membrana/imunologia , Camundongos , Mutagênese Sítio-Dirigida , Oligopeptídeos/farmacologia , Neoplasias Ovarianas/tratamento farmacológico , Ratos , Ratos Sprague-Dawley , Compostos de Sulfidrila/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA